Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

     
Restep HOME
Enhanced COMFORT

Scientific SUMMARY

Peer-reviewed scientific literature provides extensive data which establishes that compression sleeve therapy works by augmenting both the speed and volume of deep venous blood flow in the leg[1] [2], thereby preventing stasis and resultant blood clots. The literature establishes that compression sleeve therapy is as effective in reducing the incidence of Deep Vein Thrombosis (DVT) as low molecular weight heparin[3] or Enoxaparin[4], but with a significantly lower rate of bleeding complications. The literature also demonstrates that patient compliance plays a role in effective application of this therapy[5] and that a mobile compression device improved patient compliance[6].

In laboratory evaluation, Restep demonstrated augmentation of blood flow of 127-192% in the popliteal vein for calf compression and of 170-550% in the posterior tibial vein for foot compression. The longer, slightly slower inflation time of Restep means the velocity augmentation lasts for a longer time than most systems, and increased blood flow velocity over a longer time means that a greater volume of blood is being pushed towards the heart. More information available within Stryker Sustainability Solutions':
 ‘A Review of Pneumatic Compression Systems: The Science Behind Restep’.

1. Westrich GH, Specht LM, Sharrock NE, Windsor RE, Sculco TP, Haas SB, Trombley JF, Peterson M. Venous hemodynamics after total knee arthroplasty: evaluation of active dorsal to plantar flexion and several mechanical compression devices. J Bone Joint Surg Br. 1998 Nov; 80(6):1057-66.

2. Flam E, Berry S, Coyle A, Dardik H, Raab L. Blood-flow augmentation of intermittent pneumatic compression systems used for the prevention of deep vein thrombosis prior to surgery. Am J Surg. 1996;171:312-5.

3. Ginzburg E, Cohn SM, Lopez J, Jackowski J, Brown M, Hameed SM. Randomized clinical trial of intermittent pneumatic compression and low molecular weight heparin in trauma. Br J Surg. 2003 Nov;90(11):1338-44.

4. Stone MH, Limb D, Campbell P, Stead D, Culleton G. A comparison of intermittent calf compression and enoxaparin for thromboprophylaxis in total hip replacement. A pilot study. Int Orthop. 1996;20(6):367-9.

5. Vanek VW. Meta-analysis of effectiveness of intermittent pneumatic compression devices with a comparison of thigh-high to knee-high sleeves. Am Surg. 1998 Nov;64(11):1050-8.

6. Colwell CW, Froimson MI, Mont MA, Ritter MA, Trousdale RT, Buehler KC, Spitzer A, Donaldson TK, Padgett DE. Thrombosis prevention after total hip arthroplasty: a prospective, randomized trial comparing a mobile compression device with low-molecular-weight heparin. J Bone Joint Surg Am. 2010 Mar;92(3):527-35.


facebook twitter LinkedIn LinkedIn flickr YouTube facebook twitter LinkedIn flickr youtube Email